Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. immune reaction
Show results for
Products
Services

Companies

News
Articles

Refine by
Date

  • Older

Immune Reaction Articles & Analysis

10 news found

CEPI’s $3.6B Initiative with ExcellGene: Single Molecule for Global Defense in COVID Trials

CEPI’s $3.6B Initiative with ExcellGene: Single Molecule for Global Defense in COVID Trials

In fact, ExcellGene demonstrated that a single 40 L bioreactor based production run can provide antigens in sufficient quantity to immunize about 5 million people, i.e. half of the Swiss population. Most promising data were shared on an ExcellGene patented principle for generating chimaeric antigens. ...

ByExcellGene SA


Creative Enzymes Expands Its Service Offering with the Launch of Native Horseradish Peroxidase

Creative Enzymes Expands Its Service Offering with the Launch of Native Horseradish Peroxidase

It can be used not only as an indicator in biochemical reactions but also as a labeling reagent in immune reactions (especially ELISA) and is a key raw material for enzyme-labeled antibodies. ...

ByCreative Enzymes


The Essential Guide to Food Allergies

The Essential Guide to Food Allergies

Toddlers often have more severe reactions, displaying all symptoms of an allergic reaction including vomiting. ...

ByHYCOR Biomedical


Second grant win to research Peritoneal Dialysis indication

Second grant win to research Peritoneal Dialysis indication

Invizius Limited (“Invizius”), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today announces that it has been awarded a second Biomedical Catalyst grant (Feasibility & Primer Award) by Innovate UK to research a new field of application for its H-Guard technology. ...

ByInvizius Limited


Vaccines for Infectious Diseases: How Do They Work?

Vaccines for Infectious Diseases: How Do They Work?

The goal of any vaccine is to generate immunity to pathogens, in order to reduce the spread of infectious diseases. ...

ByEnGen Bio LLC


First patient treated in TIKOMED’s Phase II study of clinical islet transplantation in patients with brittle diabetes

First patient treated in TIKOMED’s Phase II study of clinical islet transplantation in patients with brittle diabetes

In the NNCIT-02 study, brittle diabetes patients being transplanted with islets of Langerhans are treated with IBSOLVMIR® which has shown to be able to address the instant blood-mediated inflammatory reaction (IBMIR) occurring as an innate immune reaction to the infusion of transplanted cells. ...

ByTIKOMED AB


AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

However, there is a much greater need for research into implants that are intended to replace elastic tissue, because the demands on the materials are high: they must retain their mechanical properties for many years, be 100 percent resistant and biocompatible, and must not cause rejection reactions by the immune system. The latter is particularly important for ...

ByAdjuCor GmbH


FDA Approves BAVENCIO (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

FDA Approves BAVENCIO (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

Serious adverse reactions occurred in 35% of patients receiving BAVENCIO in combination with axitinib. ...

BySiemens AG


Formaldehyde in Clothes, is it Cause for Health Concerns?

Formaldehyde in Clothes, is it Cause for Health Concerns?

Formaldehyde in fabrics can cause allergic reactions for some people and several major international institutions have labeled formaldehyde as a known human carcinogen. ...

ByEMSL Analytical, Inc.


Merck to initiate proof-of-concept study of posaconazole for chronic chagas disease, recognized by WHO as one of the world`s neglected tropical diseases

Merck to initiate proof-of-concept study of posaconazole for chronic chagas disease, recognized by WHO as one of the world`s neglected tropical diseases

The study will utilize polymerase chain reaction (PCR) to evaluate the levels of Trypanosoma cruzi in blood samples as the primary endpoint for response to treatment. ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT